Caspase-8 polymorphisms and risk of oral squamous cell carcinoma

Tang,Yi; Liu,Yang; Zhao,Wei; Yu,Tao; Yu,Haiyang

doi:10.3892/etm.2015.2832

Caspase-8 polymorphisms and risk of oral squamous cell carcinoma

Authors:
- Yi Tang
- Yang Liu
- Wei Zhao
- Tao Yu
- Haiyang Yu
View Affiliations

Affiliations: State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Department of Head and Neck Oncology, Sichuan Cancer Hospital, Chengdu, Sichuan 610041, P.R. China
Published online on: October 26, 2015 https://doi.org/10.3892/etm.2015.2832
Pages: 2267-2276

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Caspase-8 (CASP8) is a key controller of apoptosis, and its deregulation is crucially involved in carcinogenesis. The aim of the present study was to evaluate the function of CASP8 polymorphisms in oral squamous carcinoma (OSCC) by evaluating the risk associated with three single‑nucleotide polymorphisms (SNPs) in a case‑control study in a Han Chinese patient population. A total of 505 individuals with clinically diagnosed OSCC and 507 healthy controls were tested for the three SNPs rs3834129, rs13016963 and rs1045485, using polymerase chain reaction‑restriction fragment length polymorphism (PCR‑RFLP) and DNA sequencing analysis. After adjusting for other confounders, the genotype frequencies of CASP8 ‑652 6N ins/del promoter polymorphism (rs3834129) were found to be lower in patients with OSCC compared with normal subjects. No significant difference was detected in the genotype frequencies of rs13016963 between the patients and control subjects. However, the AA genotype frequency of rs1306963 was associated with OSCC as a risk factor among non‑smokers and non‑drinkers. For CASP8, rs1045485 was not present in any of the patients with OSCC or control subjects. These results suggest that the del allele of rs3834129 may play a protective role in the tumorigenesis of OSCC and may be useful as a genetic susceptibility marker for OSCC in the population studied.

View Figures

View References

1	Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
2	Kessler P, Grabenbauer G, Leher A, Bloch-Birkholz A, Vairaktaris E and Neukam FW: Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma long-term survival in a prospective, non-randomized study. Br J Oral Maxillofac Surg. 46:1–5. 2008. View Article : Google Scholar : PubMed/NCBI
3	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
4	Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J and Whelan S: Head and neck cancer: A global perspective on epidemiology and prognosis. Anticancer Res. 18:4779–4786. 1998.PubMed/NCBI
5	de Maria S, Lo Muzio L, Braca A, et al: Survivin promoter-31 G/C polymorphism in oral cancer cell lines. Oncol Lett. 2:935–939. 2011.PubMed/NCBI
6	Liu Y, Zha L, Li B, Zhang L, Yu T and Li L: Correlation between superoxide dismutase 1 and 2 polymorphisms and susceptibility to oral squamous cell carcinoma. Exp Ther Med. 7:171–178. 2014.PubMed/NCBI
7	Wang Y, Long L, Li T, et al: Polymorphisms of microRNA-binding sites in integrin genes are associated with oral squamous cell carcinoma susceptibility and progression. Tohoku J Exp Med. 233:33–41. 2014. View Article : Google Scholar : PubMed/NCBI
8	Zhong F, Yang XC, Bu LX, Li NY and Chen WT: Single nucleotide polymorphisms in the u-PA gene are related to susceptibility to oral tongue squamous cell carcinoma in the Northern Chinese Han population. Asian Pac J Cancer Prev. 14:781–784. 2013. View Article : Google Scholar : PubMed/NCBI
9	Hengartner MO: The biochemistry of apoptosis. Nature. 407:770–776. 2000. View Article : Google Scholar : PubMed/NCBI
10	Siegel RM: Caspases at the crossroads of immune-cell life and death. Nat Rev Immunol. 6:308–317. 2006. View Article : Google Scholar : PubMed/NCBI
11	Stupack DG: Caspase-8 as a therapeutic target in cancer. Cancer Lett. 332:133–140. 2013. View Article : Google Scholar : PubMed/NCBI
12	Grenet J, Teitz T, Wei T, Valentine V and Kidd VJ: Structure and chromosome localization of the human CASP8 gene. Gene. 226:225–232. 1999. View Article : Google Scholar : PubMed/NCBI
13	Nunez G, Benedict MA, Hu Y and Inohara N: Caspases: The proteases of the apoptotic pathway. Oncogene. 17:3237–3245. 1998. View Article : Google Scholar : PubMed/NCBI
14	Frank B, Hemminki K, Wappenschmidt B, et al: Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis. 27:606–609. 2006. View Article : Google Scholar : PubMed/NCBI
15	Palanca Suela S, Esteban Cardenosa E, Barragán González E, et al: CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. Breast Cancer Res Treat. 119:87–93. 2010. View Article : Google Scholar : PubMed/NCBI
16	Yang C, Liu HZ and Fu ZX: PEG-liposomal oxaliplatin induces apoptosis in human colorectal cancer cells via Fas/FasL and caspase-8. Cell Biol Int. 36:289–296. 2012. View Article : Google Scholar : PubMed/NCBI
17	Engel C, Versmold B, Wappenschmidt B, et al: Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 19:2859–2868. 2010. View Article : Google Scholar : PubMed/NCBI
18	Lubahn J, Berndt SI, Jin CH, et al: Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma. Prostate. 70:646–653. 2010.PubMed/NCBI
19	Bethke L, Sullivan K, Webb E, et al: CASP8 D302H and meningioma risk: An analysis of five case-control series. Cancer Lett. 273:312–315. 2009. View Article : Google Scholar : PubMed/NCBI
20	Bethke L, Sullivan K, Webb E, et al: The common D302H variant of CASP8 is associated with risk of glioma. Cancer Epidemiol Biomarkers Prev. 17:987–989. 2008. View Article : Google Scholar : PubMed/NCBI
21	Sun T, Gao Y, Tan W, et al: A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet. 39:605–613. 2007. View Article : Google Scholar : PubMed/NCBI
22	Barrett JH, Iles MM, Harland M, et al: GenoMel Consortium: Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet. 43:1108–1113. 2011. View Article : Google Scholar : PubMed/NCBI
23	Abnet CC, Wang Z, Song X, et al: Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: A meta-analysis of genome-wide association studies. Hum Mol Genet. 21:2132–2141. 2012. View Article : Google Scholar : PubMed/NCBI
24	Sergentanis TN and Economopoulos KP: Association of two CASP8 polymorphisms with breast cancer risk: A meta-analysis. Breast Cancer Res Treat. 120:229–234. 2010. View Article : Google Scholar : PubMed/NCBI
25	Pindborg JJ, Reichart PA, Smith CJ and van der Waal I: Histological Typing of Cancer and Precancer of the Oral Mucosa (2nd). Berlin: Springer-Verlag. 1997. View Article : Google Scholar
26	Green FL: AJCC Cancer Staging Manual (6th). Berlin Heidelberg: Springer-Verlag. 2002. View Article : Google Scholar
27	Miller SA, Dykes DD and Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:12151988. View Article : Google Scholar : PubMed/NCBI
28	Hashemi M, Eskandari-Nasab E, Fazaeli A, et al: Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 −652 6 N ins/del promoter polymorphism (rs3834129) in breast cancer. Gene. 505:176–179. 2012. View Article : Google Scholar : PubMed/NCBI
29	Hu Z, Li C, Chen K, et al: Single nucleotide polymorphisms in selected apoptotic genes and BPDE-induced apoptotic capacity in apparently normal primary lymphocytes: A genotype-phenotype correlation analysis. J Cancer Epidemiol. 2008:1479052008. View Article : Google Scholar : PubMed/NCBI
30	Shi YY and He L: SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction and genetic association at polymorphism loci. Cell Res. 15:97–98. 2005. View Article : Google Scholar : PubMed/NCBI
31	Lewontin R: On measures of gametic disequilibrium. Genetics. 120:849–852. 1988.PubMed/NCBI
32	Hudson RR: The sampling distribution of linkage disequilibrium under an infinite allele model without selection. Genetics. 109:611–631. 1985.PubMed/NCBI
33	Jemal A: Global burden of cancer: Opportunities for prevention. Lancet. 380:1797–1799. 2012. View Article : Google Scholar : PubMed/NCBI
34	Chawla JP, Iyer N, Soodan KS, Sharma A, Khurana SK and Priyadarshni P: Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein-Barr virus and human papillomaviruses: With special reference to oral cancer. Oral Oncol. 51:731–737. 2015. View Article : Google Scholar : PubMed/NCBI
35	Srinivas PR, Kramer BS and Srivastava S: Trends in biomarker research for cancer detection. Lancet Oncol. 2:698–704. 2001. View Article : Google Scholar : PubMed/NCBI
36	Wang M and Zhang Z, Tian Y, Shao J and Zhang Z: A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter associated with risk and progression of bladder cancer. Clin Cancer Res. 15:2567–2572. 2009. View Article : Google Scholar : PubMed/NCBI
37	Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001. View Article : Google Scholar : PubMed/NCBI
38	Lowe SW and Lin AW: Apoptosis in cancer. Carcinogenesis. 21:485–495. 2000. View Article : Google Scholar : PubMed/NCBI
39	Andersen MH, Becker JC and Straten P: Regulators of apoptosis: suitable targets for immune therapy of cancer. Nat Rev Drug Discov. 4:399–409. 2005. View Article : Google Scholar : PubMed/NCBI
40	Hsing AW, Sakoda LC, Rashid A, et al: Variants in inflammation genes and the risk of biliary tract cancers and stones: A population-based study in China. Cancer Res. 68:6442–6452. 2008. View Article : Google Scholar : PubMed/NCBI
41	Srivastava A, Srivastava K, Pandey SN, Choudhuri G and Mittal B: Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: Association with gallbladder cancer in North Indian population. Ann Surg Oncol. 16:1695–1703. 2009. View Article : Google Scholar : PubMed/NCBI
42	Srivastava K, Srivastava A, Pandey SN, Kumar A and Mittal B: Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population. J Gastroenterol. 44:774–780. 2009. View Article : Google Scholar : PubMed/NCBI
43	Srivastava K, Srivastava A and Mittal B: Caspase-8 polymorphisms and risk of gallbladder cancer in a northern Indian population. Mol Carcinog. 49:684–692. 2010.PubMed/NCBI
44	Li C, Lu J, Liu Z, et al: The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck. Cancer Prev Res (Phila). 3:246–253. 2010. View Article : Google Scholar : PubMed/NCBI
45	Frank B, Rigas SH, Bermejo JL, et al: The CASP8 −652 6 N del promoter polymorphism and breast cancer risk: A multicenter study. Breast Cancer Res Treat. 111:139–144. 2008. View Article : Google Scholar : PubMed/NCBI
46	De Vecchi G, Verderio P, Pizzamiglio S, et al: Evidences for association of the CASP8 −652 6 N del promoter polymorphism with age at diagnosis in familial breast cancer cases. Breast Cancer Res Treat. 113:607–608. 2009. View Article : Google Scholar : PubMed/NCBI
47	Haiman CA, Garcia RR, Kolonel LN, Henderson BE, Wu AH and Le Marchand L: A promoter polymorphism in the CASP8 gene is not associated with cancer risk. Nat Genet. 40:259–260. 2008. View Article : Google Scholar : PubMed/NCBI